Synbio Tech Inc.
Synbio Tech Inc. manufactures and sells human healthcare products and probiotics for animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. The company also provides single probiotic strain and multi strain probiotics, and functional strain. Its functional s… Read more
Synbio Tech Inc. (1295) - Total Liabilities
Latest total liabilities as of September 2025: NT$1.58 Billion TWD
Based on the latest financial reports, Synbio Tech Inc. (1295) has total liabilities worth NT$1.58 Billion TWD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Synbio Tech Inc. - Total Liabilities Trend (2020–2024)
This chart illustrates how Synbio Tech Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Synbio Tech Inc. Competitors by Total Liabilities
The table below lists competitors of Synbio Tech Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Baron Capital
PINK:BCAP
|
USA | $675.90K |
|
Human Xtensions Ltd
TA:HUMX
|
Israel | ILA3.66 Million |
|
YAHOO JAPAN
BE:YOJ
|
Germany | €6.96 Trillion |
|
KEY TRONIC
BE:KT1
|
Germany | €231.59 Million |
|
ARYZTA N
MU:YZA
|
Germany | €1.17 Billion |
|
TAURON
MU:1T5
|
Germany | €27.89 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down Synbio Tech Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Synbio Tech Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Synbio Tech Inc. (2020–2024)
The table below shows the annual total liabilities of Synbio Tech Inc. from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$1.27 Billion | +34.12% |
| 2023-12-31 | NT$943.27 Million | +21.08% |
| 2022-12-31 | NT$779.07 Million | +16.29% |
| 2021-12-31 | NT$669.93 Million | +6.87% |
| 2020-12-31 | NT$626.89 Million | -- |